Ignite Creation Date:
2025-12-24 @ 11:53 AM
Ignite Modification Date:
2026-04-11 @ 11:14 PM
Study NCT ID:
NCT03183661
Status:
RECRUITING
Last Update Posted:
2023-08-25
First Post:
2017-06-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Follow-up Study to Evaluate the Safety of ALLO-ASC-CD in ALLO-ASC-CD-101 Clinical Trial
Sponsor:
Anterogen Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-11-16
Start Date Type:
ACTUAL
Primary Completion Date:
2026-12-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2017-06-08
First Submit QC Date:
None
Study First Post Date:
2017-06-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-08-23
Last Update Post Date:
2023-08-25
Last Update Post Date Type:
ACTUAL